PCI治疗-话题@MedSci - 梅斯（MedSci）

#PCI治疗#

32篇内容 | 1903人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2180932, encodeId=91b321809320b, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a> <a href='/topic/show?id=1ea455e6064' target=_blank style='color:#2F92EE;'>#抗血栓治疗#</a>, objectTitle=≥75 岁接受 PCI 治疗的患者抗血栓治疗策略决策, objectType=article, longId=809036, objectId=c09a80903648, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hemorrhoids-s11-photo-of-doctor-discussing-diagnosis-with-patient.jpg, objectUrl=/article/show_article.do?id=c09a80903648, replyNumber=0, likeNumber=100, createdTime=2024-01-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c09a80903648, moduleTitle=≥75 岁接受 PCI 治疗的患者抗血栓治疗策略决策, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c09a80903648)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2030106, encodeId=11172030106d8, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=2021 CCHC：病例大赛！重视血流管理，让PCI治疗获益不打折, objectType=article, longId=292488, objectId=617e29248875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=617e29248875, replyNumber=0, likeNumber=114, createdTime=2022-04-16, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=617e29248875, moduleTitle=2021 CCHC：病例大赛！重视血流管理，让PCI治疗获益不打折, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=617e29248875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030108, encodeId=cf112030108a3, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=European Radiology：纳入这一参数的CCTA评分系统可实现PCI治疗效果的预测, objectType=article, longId=724420, objectId=1050e2442020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1050e2442020, replyNumber=0, likeNumber=100, createdTime=2022-12-19, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1050e2442020, moduleTitle=European Radiology：纳入这一参数的CCTA评分系统可实现PCI治疗效果的预测, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1050e2442020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030107, encodeId=7c4d203010ea3, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=JACC：围手术期心肌梗死在接受PCI治疗的慢性冠脉综合征患者中的发生率及预后意义, objectType=article, longId=299758, objectId=920f299e58d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920f299e58d9, replyNumber=0, likeNumber=100, createdTime=2022-07-19, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920f299e58d9, moduleTitle=JACC：围手术期心肌梗死在接受PCI治疗的慢性冠脉综合征患者中的发生率及预后意义, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=920f299e58d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030104, encodeId=681f203010442, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=Cardiovasc Diabetol：纤维蛋白原对PCI治疗后的CAD患者的长期死亡率的预测价值, objectType=article, longId=214717, objectId=5b5f214e1795, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b5f214e1795, replyNumber=0, likeNumber=108, createdTime=2022-03-22, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b5f214e1795, moduleTitle=Cardiovasc Diabetol：纤维蛋白原对PCI治疗后的CAD患者的长期死亡率的预测价值, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5b5f214e1795)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030105, encodeId=2bc220301051b, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=NEJM：FFR和血管造影指导下的多支血管PCI治疗心肌梗死比较（FLOWER-MI研究）, objectType=article, longId=214809, objectId=5c1721480995, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1721480995, replyNumber=0, likeNumber=116, createdTime=2022-04-20, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1721480995, moduleTitle=NEJM：FFR和血管造影指导下的多支血管PCI治疗心肌梗死比较（FLOWER-MI研究）, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c1721480995)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030103, encodeId=66df20301037e, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=JAHA：CTO患者行PCI治疗的益处在哪里？-在10年后, objectType=article, longId=207937, objectId=31b720e93799, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31b720e93799, replyNumber=0, likeNumber=130, createdTime=2021-04-25, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31b720e93799, moduleTitle=JAHA：CTO患者行PCI治疗的益处在哪里？-在10年后, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=31b720e93799)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030102, encodeId=aad820301020d, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=王效增：PSP优化策略应用于复杂病变PCI治疗的新局面, objectType=article, longId=205028, objectId=12a8205028fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12a8205028fa, replyNumber=0, likeNumber=91, createdTime=2021-07-16, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12a8205028fa, moduleTitle=王效增：PSP优化策略应用于复杂病变PCI治疗的新局面, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=12a8205028fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030101, encodeId=503b2030101d8, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=EUR HEART J-CARD PHA：接受PCI治疗的心肌梗死患者接受无规划糖蛋白IIb/IIIa抑制剂的p2y12抑制剂患者的肝素抗凝程度与临床结果的关系, objectType=article, longId=187475, objectId=0c5518e475ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c5518e475ae, replyNumber=0, likeNumber=95, createdTime=2020-04-05, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c5518e475ae, moduleTitle=EUR HEART J-CARD PHA：接受PCI治疗的心肌梗死患者接受无规划糖蛋白IIb/IIIa抑制剂的p2y12抑制剂患者的肝素抗凝程度与临床结果的关系, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0c5518e475ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030099, encodeId=510e2030099d1, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=【病例精选】OCT指导下冠状动脉分叉病变的PCI治疗一例, objectType=article, longId=166476, objectId=f3061664e671, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3061664e671, replyNumber=0, likeNumber=88, createdTime=2020-05-03, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3061664e671, moduleTitle=【病例精选】OCT指导下冠状动脉分叉病变的PCI治疗一例, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f3061664e671)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030100, encodeId=deaa2030100bc, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=2019 共识文件：接受PCI治疗患者高出血风险的定义, objectType=article, longId=166929, objectId=7eb51669290c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7eb51669290c, replyNumber=0, likeNumber=99, createdTime=2020-01-05, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7eb51669290c, moduleTitle=2019 共识文件：接受PCI治疗患者高出血风险的定义, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7eb51669290c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030098, encodeId=620b203009836, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=Yonsei Med J：药物洗脱支架进行CTO-PCI治疗的效果优于单纯药物治疗, objectType=article, longId=143000, objectId=71c114300015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71c114300015, replyNumber=0, likeNumber=95, createdTime=2019-01-30, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71c114300015, moduleTitle=Yonsei Med J：药物洗脱支架进行CTO-PCI治疗的效果优于单纯药物治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=71c114300015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030091, encodeId=40f52030091ca, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=JACC：STEMI患者PCI治疗后缺血和出血事件发生风险的比较, objectType=article, longId=115211, objectId=7b3011521125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b3011521125, replyNumber=0, likeNumber=77, createdTime=2018-03-11, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b3011521125, moduleTitle=JACC：STEMI患者PCI治疗后缺血和出血事件发生风险的比较, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=7b3011521125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030097, encodeId=de1f203009e1e, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=Circ：Cardiovasc Inte：PCI治疗后病因特异性死亡率的性别差异, objectType=article, longId=132828, objectId=341613282829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=341613282829, replyNumber=0, likeNumber=114, createdTime=2018-08-23, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=341613282829, moduleTitle=Circ：Cardiovasc Inte：PCI治疗后病因特异性死亡率的性别差异, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=341613282829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030095, encodeId=8fce2030095f9, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=JAHA：接受PCI治疗的退伍军人对高强度他汀类药物治疗的依从性研究, objectType=article, longId=131498, objectId=841313149869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=841313149869, replyNumber=0, likeNumber=117, createdTime=2019-01-27, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=841313149869, moduleTitle=JAHA：接受PCI治疗的退伍军人对高强度他汀类药物治疗的依从性研究, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=841313149869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030090, encodeId=57612030090f8, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=JACC：机器人辅助PCI治疗复杂冠脉病变的安全性和可行性, objectType=article, longId=104528, objectId=c60410452812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60410452812, replyNumber=0, likeNumber=86, createdTime=2017-12-05, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60410452812, moduleTitle=JACC：机器人辅助PCI治疗复杂冠脉病变的安全性和可行性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c60410452812)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030096, encodeId=3953203009661, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=Circ-Cardiovasc Inte：替卡格雷预处理对接受PCI治疗的急性ST段抬高心肌梗死患者无益！, objectType=article, longId=132670, objectId=1c801326e098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c801326e098, replyNumber=0, likeNumber=0, createdTime=2019-01-22, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c801326e098, moduleTitle=Circ-Cardiovasc Inte：替卡格雷预处理对接受PCI治疗的急性ST段抬高心肌梗死患者无益！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1c801326e098)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030094, encodeId=41dc203009476, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=JAHA：ACS患者PCI治疗后吸烟决定服用双倍剂量还是标准剂量氯吡格雷！, objectType=article, longId=118727, objectId=a1d9118e27e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1d9118e27e8, replyNumber=0, likeNumber=110, createdTime=2018-02-24, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1d9118e27e8, moduleTitle=JAHA：ACS患者PCI治疗后吸烟决定服用双倍剂量还是标准剂量氯吡格雷！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a1d9118e27e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030093, encodeId=1fe02030093fd, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=JAHA：心梗PCI治疗后心绞痛的治疗管理, objectType=article, longId=116922, objectId=fd801169227b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd801169227b, replyNumber=0, likeNumber=96, createdTime=2018-03-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd801169227b, moduleTitle=JAHA：心梗PCI治疗后心绞痛的治疗管理, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fd801169227b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2030092, encodeId=51ed2030092c6, content=<a href='/topic/show?id=a96d13850d7' target=_blank style='color:#2F92EE;'>#PCI治疗#</a>, objectTitle=Circulation：多学科讨论：这个药能降低急诊PCI治疗的STEMI患者心肌梗死面积, objectType=article, longId=116088, objectId=6c46116088ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c46116088ad, replyNumber=0, likeNumber=81, createdTime=2018-05-14, rootId=0, userName=ms5187542471278033, userId=ec952500165, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c46116088ad, moduleTitle=Circulation：多学科讨论：这个药能降低急诊PCI治疗的STEMI患者心肌梗死面积, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6c46116088ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PCI治疗

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#PCI治疗# #抗血栓治疗#

≥75 岁接受 PCI 治疗的患者抗血栓治疗策略决策

2024-01-12发表于上海

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

2021 CCHC：病例大赛！重视血流管理，让PCI治疗获益不打折

2022-04-16

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

European Radiology：纳入这一参数的CCTA评分系统可实现PCI治疗效果的预测

2022-12-19

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

JACC：围手术期心肌梗死在接受PCI治疗的慢性冠脉综合征患者中的发生率及预后意义

2022-07-19

智慧医人 (审核中...)

前往app查看评论内容

#PCI治疗#

Cardiovasc Diabetol：纤维蛋白原对PCI治疗后的CAD患者的长期死亡率的预测价值

2022-03-22

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

NEJM：FFR和血管造影指导下的多支血管PCI治疗心肌梗死比较（FLOWER-MI研究）

2022-04-20

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

JAHA：CTO患者行PCI治疗的益处在哪里？-在10年后

2021-04-25

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

王效增：PSP优化策略应用于复杂病变PCI治疗的新局面

2021-07-16

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

EUR HEART J-CARD PHA：接受PCI治疗的心肌梗死患者接受无规划糖蛋白IIb/IIIa抑制剂的p2y12抑制剂患者的肝素抗凝程度与临床结果的关系

2020-04-05

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

【病例精选】OCT指导下冠状动脉分叉病变的PCI治疗一例

2020-05-03

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

2019 共识文件：接受PCI治疗患者高出血风险的定义

2020-01-05

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

Yonsei Med J：药物洗脱支架进行CTO-PCI治疗的效果优于单纯药物治疗

2019-01-30

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

JACC：STEMI患者PCI治疗后缺血和出血事件发生风险的比较

2018-03-11

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

Circ：Cardiovasc Inte：PCI治疗后病因特异性死亡率的性别差异

2018-08-23

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

JAHA：接受PCI治疗的退伍军人对高强度他汀类药物治疗的依从性研究

2019-01-27

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

JACC：机器人辅助PCI治疗复杂冠脉病变的安全性和可行性

2017-12-05

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

Circ-Cardiovasc Inte：替卡格雷预处理对接受PCI治疗的急性ST段抬高心肌梗死患者无益！

2019-01-22

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

JAHA：ACS患者PCI治疗后吸烟决定服用双倍剂量还是标准剂量氯吡格雷！

2018-02-24

hb2008ye (审核中...)

前往app查看评论内容

#PCI治疗#

JAHA：心梗PCI治疗后心绞痛的治疗管理

2018-03-31

ms5187542471278033 (审核中...)

前往app查看评论内容

#PCI治疗#

Circulation：多学科讨论：这个药能降低急诊PCI治疗的STEMI患者心肌梗死面积

2018-05-14

科室
- - 订阅+
  - 更多科室
工具
服务